Unibest
← Back to patent-cliff list

CAS 112-27-6

2,2'-(ethane-1,2-diylbis(oxy))bis(ethan-1-ol)

Codes: FLORB-001, ICOT-001

Application context (from source-drug indications)

Alzheimer's diseaseFlorbetapir(18F)Contrast imagingFlorbetapir(18F)GlioblastomaFlorbetapir(18F)Neurodegenerative diseaseFlorbetapir(18F)Frontotemporal dementiaFlorbetapir(18F)Mild cognitive impairmentFlorbetapir(18F)Non-small cell lung cancerIcotinib HydrochlorideLung adenocarcinomaIcotinib HydrochlorideBronchial neoplasmIcotinib HydrochlorideLung cancerIcotinib HydrochlorideMetastatic breast cancerIcotinib HydrochloridePsoriasisIcotinib Hydrochloride

Source drugs (routes using this intermediate)

DrugTierExpiry
Florbetapir(18F)Tier C — Watch / trade-
Icotinib HydrochlorideTier C — Watch / trade-

Position in synthesis routes (up/downstream chain)

Ordered by route registration; left → right is the synthesis direction. The highlighted node is the current CAS; others link to their own profiles.

Intermediates available on this site

No listed intermediates for this target yet — send an RFQ directly and it will enter our matching pool.

This is a CAS-level registry record: registrations across routes are merged. Supplier offers and buyer demands will be matched on this CAS as the primary key.